| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |